Lung cancer: open trials in Serbia

8 open trials have a site in Serbia. Registry data; only the trial team decides who can take part.

NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.
Univerzitetski Klinicki Centar Srbije, Belgrade · Institute for Pulmonary Diseases of Vojvodina, Kamenitz · Local Institution - 007-694, Kragujevac · Uzice General Hospital, Užice
Registry updated 2026-10-30
NCT06996782
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 1/2 · AstraZeneca
Belgrade · Kragujevac · Niš
Registry updated 2026-10-28
NCT07155174
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Trial Treatment · Phase 2 · AbbVie
University Clinical Center Serbia /ID# 277007, Belgrade · Clinical Hospital Center - Bezanijska Kosa /ID# 277013, Belgrade · Institute For Pulmonary Diseases Of Vojvodina /ID# 277003, Kamenitz · University Clinical Center Kragujevac /ID# 277179, Kragujevac · University Clinical Center Nis /ID# 277180, Niš
Registry updated 2026-10-27
NCT06568939
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 2 · AbbVie
Clinical Hospital Center - Bezanijska Kosa /ID# 270558, Belgrade · Military Medical Academy /ID# 279873, Belgrade · Institute for Oncology and Radiology of Serbia /ID# 270561, Belgrade · University Clinical Center Serbia /ID# 270808, Belgrade · Institute For Pulmonary Diseases Of Vojvodina /ID# 270559, Kamenitz · University Clinical Center Kragujevac /ID# 275773, Kragujevac · University Clinical Center Nis /ID# 270557, Niš
Registry updated 2026-10-22
NCT07625644
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Trial Treatment · Phase 3 · SystImmune Inc.
University Clinical Centre of Serbia, Clinic for pulmonology, Belgrade · University Hospital Medical Center Bezanijska Kosa, Belgrade · University Clinical Center Kragujevac, Kragujevac · Institute for pulmonary diseases of Vojvodina, Novi Sad
Registry updated 2026-10-15
NCT07155187
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Trial Treatment · Phase 2/3 · AbbVie
University Clinical Center Serbia /ID# 277051, Belgrade · Military Medical Academy /ID# 277053, Belgrade · Clinical Hospital Center - Bezanijska Kosa /ID# 277052, Belgrade · Institute For Pulmonary Diseases Of Vojvodina /ID# 277047, Kamenitz · University Clinical Center Kragujevac /ID# 277162, Kragujevac · University Clinical Center Nis /ID# 277200, Niš
Registry updated 2026-10-05
NCT06767514
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Trial Treatment · Phase 3 · Summit Therapeutics
Belgrade · Kragujevac · Novi Sad
Registry updated 2026-09-18
NCT07391813
SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer
Trial Treatment · Phase 1/2 · SN BioScience
The Institute for Pulmonary Diseases of Vojvodina, Kamenitz
Registry updated 2026-03-09

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error